Impax Asset Management Group plc trimmed its holdings in shares of Ecolab Inc. (NYSE:ECL – Free Report) by 12.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 663,023 shares of the basic materials company’s stock after selling 97,864 shares during the period. Impax Asset Management Group plc owned about 0.23% of Ecolab worth $169,290,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in ECL. NBC Securities Inc. boosted its stake in shares of Ecolab by 2.3% in the third quarter. NBC Securities Inc. now owns 1,778 shares of the basic materials company’s stock valued at $453,000 after purchasing an additional 40 shares during the period. Community Financial Services Group LLC grew its stake in Ecolab by 0.3% during the 3rd quarter. Community Financial Services Group LLC now owns 15,429 shares of the basic materials company’s stock worth $3,940,000 after buying an additional 40 shares during the last quarter. Angeles Wealth Management LLC increased its holdings in shares of Ecolab by 3.0% in the 3rd quarter. Angeles Wealth Management LLC now owns 1,391 shares of the basic materials company’s stock worth $355,000 after acquiring an additional 41 shares during the period. Bangor Savings Bank increased its stake in shares of Ecolab by 17.3% in the third quarter. Bangor Savings Bank now owns 292 shares of the basic materials company’s stock valued at $75,000 after purchasing an additional 43 shares during the period. Finally, Pine Haven Investment Counsel Inc increased its position in Ecolab by 1.6% in the 2nd quarter. Pine Haven Investment Counsel Inc now owns 2,840 shares of the basic materials company’s stock valued at $676,000 after acquiring an additional 44 shares during the period. Institutional investors and hedge funds own 74.91% of the company’s stock.
Ecolab Trading Down 0.0 %
Shares of NYSE:ECL opened at $244.50 on Tuesday. The company has a market cap of $69.57 billion, a P/E ratio of 34.29, a P/E/G ratio of 2.48 and a beta of 1.13. The stock’s 50-day moving average is $252.59 and its 200-day moving average is $242.28. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.97 and a current ratio of 1.30. Ecolab Inc. has a 52-week low of $172.79 and a 52-week high of $262.61.
Insider Buying and Selling
In related news, major shareholder William H. Gates III sold 65,015 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $243.80, for a total value of $15,850,657.00. Following the completion of the transaction, the insider now owns 30,388,741 shares of the company’s stock, valued at $7,408,775,055.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, major shareholder William H. Gates III sold 65,015 shares of the stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $243.80, for a total transaction of $15,850,657.00. Following the completion of the sale, the insider now owns 30,388,741 shares in the company, valued at $7,408,775,055.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder William H. Gates III sold 409,136 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $246.92, for a total value of $101,023,861.12. Following the completion of the transaction, the insider now directly owns 30,776,418 shares in the company, valued at $7,599,313,132.56. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 478,355 shares of company stock valued at $117,922,965 over the last ninety days. 0.50% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of analysts have commented on ECL shares. BMO Capital Markets boosted their price target on shares of Ecolab from $260.00 to $279.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 30th. JPMorgan Chase & Co. increased their price target on Ecolab from $228.00 to $255.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Citigroup upgraded shares of Ecolab from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $267.00 to $265.00 in a research report on Wednesday, July 31st. Jefferies Financial Group upgraded Ecolab from a “hold” rating to a “buy” rating and upped their target price for the company from $235.00 to $310.00 in a report on Friday, October 18th. Finally, Morgan Stanley increased their price objective on Ecolab from $240.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 30th. Eight analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $277.20.
View Our Latest Research Report on ECL
Ecolab Company Profile
Ecolab Inc provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through three segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries.
See Also
- Five stocks we like better than Ecolab
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Intel: Is Now the Time to Be Brave?
- What Does Downgrade Mean in Investing?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is Insider Trading? What You Can Learn from Insider Trading
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Ecolab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ecolab and related companies with MarketBeat.com's FREE daily email newsletter.